Elavon wins Merchant Acquirer of the Year Award at Cards & Payments European Conference

NewsGuard 100/100 Score

At a glittering award ceremony at the Westin Grand in Frankfurt last night, Elavon, a leading global payments provider and wholly-owned subsidiary of U.S. Bancorp (NYSE: USB), was announced as winner of the Merchant Acquirer of the Year Award at the Cards & Payments Europe 2011 Conference and Awards Dinner.

Nominated along with HSBC Merchant Services and AIBMS, the award was given to "the merchant acquirer that has made a major change to the industry through expansion, technological advancements, acquisitions or other significant activities".

Cards & Payments Europe is a European Conference, running for its 24th year in 2011. It has its foundations in VRL's leading publications Cards International and Electronic Payments International.

The finalists for the awards were judged in eleven separate categories for their achievements over the last 12 months. A panel of five judges selected the winner from among those organizations nominated by readers or judges.

"We are delighted to receive this award; it acknowledges several years of very hard work to bring about the advances we were recognised for last night. Our parent company, U.S. Bancorp, invested heavily in new technology to facilitate faster and more secure processing for our customers. In Europe we are also reaping the rewards of a strong global value proposition that gives our partners and clients one source for all their payment processing needs. Relationships with banks, associations and third-party distributors that began in one country or region have now expanded; many are now doing business with us in Europe, the U.S., Canada, Mexico and Puerto Rico. But ultimately our success is because our people, processes, products and service are so strong," commented Simon Haslam, President International Operations for Elavon.

Source: Elavon

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.